Discontinued — last reported Q3 '25
Albemarle Intangibles (Net) decreased by 3.1% to $207.62M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 9.6%, from $229.74M to $207.62M. Over 5 years (FY 2020 to FY 2025), Intangibles (Net) shows a downward trend with a -9.3% CAGR.
An increase often follows strategic acquisitions or significant R&D capitalization, while a decrease may indicate amortization or impairment charges.
This represents the net book value of non-physical assets, such as patents, trademarks, software, and customer relations...
Highly relevant for healthcare and technology firms; peers often disclose the composition of these assets in financial footnotes.
intangible_assets_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $331.09M | $320.98M | $308.95M | $297.41M | $285.30M | $262.98M | $287.87M | $284.51M | $274.41M | $260.54M | $261.86M | $251.76M | $243.34M | $246.08M | $230.75M | $229.74M | $234.95M | $229.95M | $214.23M | $207.62M |
| QoQ Change | — | -3.1% | -3.7% | -3.7% | -4.1% | -7.8% | +9.5% | -1.2% | -3.5% | -5.1% | +0.5% | -3.9% | -3.3% | +1.1% | -6.2% | -0.4% | +2.3% | -2.1% | -6.8% | -3.1% |
| YoY Change | — | — | — | — | -13.8% | -18.1% | -6.8% | -4.3% | -3.8% | -0.9% | -9.0% | -11.5% | -11.3% | -5.6% | -11.9% | -8.7% | -3.4% | -6.6% | -7.2% | -9.6% |